Content Library

StageBio senior pathologist co-authors article on the use of animal models of disease for nonclinical safety testing

Currently, healthy animal models play a critical role in the safety evaluation of a drug or health product. However, pharmaceutical companies and regulatory authorities are becoming increasingly interested in the use of animal models of disease (AMD) to better understand the potential risk of a diseased population. Recent publications and recommendations for the use of these models by regulators make the growing interest of the application of AMD highly evident.

Upcoming Events

ASGCT (American Society of Gene and Cell Therapy)

May 16-19, 2022, Walter E. Washington Convention Center, Washington, D.C.

Society of French Pathology Toxicology

May 19-20, Toulouse, France
Listen to our presentation by Dr. Serge Rousselle, CSO, on the scientific value of histopathological evaluation during the nonclinical safety assessment of medical devices

Learn more about StageBio’s COVID-19 response